Search Results - "Hugonnet, F."

Whole body [18F]fluorodeoxyglucose positron emission tomography imaging for the diagnosis of pacemaker or implantable cardioverter defibrillator infection: a preliminary prospective study by Bensimhon, L., Lavergne, T., Hugonnet, F., Mainardi, J.-L., Latremouille, C., Maunoury, C., Lepillier, A., Le Heuzey, J.-Y., Faraggi, M.

“…We studied the potential use of [18F]fluorodeoxyglucose (18F-FDG) whole body positron emission tomography (PET)–computed tomography for the diagnosis of device…”
Get full text

606 Feasibility of Sentinel Lymph Node Detection with Radioisotopic Method Alone After a Grade IV Anaphylactic Reaction to Patent Blue in Breast Cancer Surgery by Gaujal, L, Malka, I, Féron, J.g, Ngo, C, Fourchotte, V, Hugonnet, F, Laki, F, Queinnec, M, De Margerie, V, Alran, S

Get full text

Validation over time of a nomogram including HER2 status to predict the sentinel node positivity in early breast carcinoma by Ngô, C, Mouttet, D, De Rycke, Y, Reyal, F, Fourchotte, V, Hugonnet, F, Falcou, M.C, Bidard, F.C, Vincent-Salomon, A, Fourquet, A, Alran, S

“…Abstract Background The molecular subtypes of breast cancer have different axillary status. A nomogram including the interaction covariate between estrogen…”
Get full text

Role of positron emission tomography (PET) in head and neck cancer by Duet, M, Hugonnet, F, Faraggi, M

“…Summary F-18 fluorodeoxyglucose positron emission tomography is now part of the initial stage III and IV cancer work-up and each time that metastasis or the…”
Get full text

Metastatic renal cell carcinoma (mRCC): Relationship between initial non-renal RECIST-target metastases hypoxia, change after 1 month of sunitinib, and therapeutic response: An 18 F-MISO PET-CT study by Hugonnet, F., Fournier, L., Oudard, S.

“…Abstract only…”
Get full text

P3-07-09: Prediction of Additional Nodal Metastasis in Breast Cancer Patients with a Positive Sentinel Node Biopsy: A New Nomogram Including HER2 Status by Ngô, C, De, Rycke Y, Castellier, C, Fourchotte, V, Hugonnet, F, Hajage, D, Reyal, F, Vincent-Salomon, A, Pierga, J-Y, Kirova, Y, Sastre-Garau, X, Alran, S

“…Abstract Background The Memorial Sloan Kettering Cancer Center-Breast Cancer Nomogram (MSKCC-BCN) predicts additional nodal metastasis in patients with…”
Get full text

PD02-08: Validation over Time of a Nomogram Predicting the Sentinel Node Positivity in Early Breast Carcinoma According to the Molecular Subtypes Classification by Ngô, C, De Rycke, Y, Mouttet, D, Reyal, F, Fourchotte, V, Hugonnet, F, Falcou, M-C, Bidard, F-C, Vincent-Salomon, A, Fourquet, A, Sigal-Zafrani, B, Alran, S

“…Abstract Background: The molecular subtypes of breast cancer have different axillary status. A new nomogram including the interaction covariate between…”
Get full text

Modification de la biodistribution non tumorale du 18FMISO, un traceur d’hypoxie, chez les patients traités par sunitinib pour cancer du rein métastatique by Champion, L., Hugonnet, F.

“…Le but de l’étude était de mettre en évidence l’influence du sunitinib sur la fixation d’un traceur de l’hypoxie, le 18F-FMISO, sur les tissus non tumoraux et…”
Get full text

Quel stress pour quelle imagerie ? by Faraggi, M., Hugonnet, F., Maunoury, C.

“…Les tests de stimulation ne sont pas physio-pathologique-ment identiques. Connaître le « stress » le mieux adapté au contexte clinique est primordial et peut…”
Get full text

Nouvelles approches isotopiques by Faraggi, M., Hugonnet, F., Maunoury, C.

“…En fonction du test de stimulation qui sera pratiqué, une imagerie sera retenue. La démarche ne doit donc pas commencer par le choix de l’imagerie mais par la…”
Get full text